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Aims

Hypoplastic coronary artery disease is a rare congenital abnormality that is associated with sudden cardiac death.
However, molecular mechanisms responsible for this disease are not clear. The aim of the present study was to
assess the role of nitric oxide synthase-3 (NOS3) in the pathogenesis of hypoplastic coronary arteries.
.....................................................................................................................................................................................
Methods
Wild-type (WT), NOS32/2 , and a novel cardiac-specific NOS3 overexpression mouse model were employed. Deand results
ficiency in NOS3 resulted in coronary artery hypoplasia in foetal mice and spontaneous myocardial infarction in postnatal hearts. Coronary artery diameters, vessel density, and volume were significantly decreased in NOS32/2 mice at
postnatal day 0. In addition, NOS32/2 mice showed a significant increase in the ventricular wall thickness, myocardial
volume, and cardiomyocyte cell size compared with WT mice. Lack of NOS3 also down-regulated the expression of
Gata4, Wilms tumour-1, vascular endothelial growth factor, basic fibroblast growth factor and erythropoietin, and
inhibited migration of epicardial cells. These abnormalities and hypoplastic coronary arteries in the NOS32/2
mice were completely rescued by the cardiac-specific overexpression of NOS3.
.....................................................................................................................................................................................
Conclusion
Nitric oxide synthase-3 is required for coronary artery development and deficiency in NOS3 leads to hypoplastic
coronary arteries.

----------------------------------------------------------------------------------------------------------------------------------------------------------Keywords

Nitric oxide synthase † Coronary artery development † Congenital heart disease

Introduction
Congenital coronary anomalies affect up to 5% of the general
population.1,2 Most of them do not have clinical signs or symptoms,
and are often unrecognized. However, severe congenital coronary
artery malformation is associated with myocardial ischaemia, infarction, and sudden cardiac death.3 Hypoplastic coronary artery
disease (HCAD), a rare congenital coronary abnormality, is
defined by malformation of one or more major branches of the
coronary arteries with a marked decrease in the luminal diameter
and length.4 – 6 Hypoplastic coronary artery disease can be asymptomatic, but is often associated with myocardial infarction and
sudden cardiac death under stress, such as during intense physical

activity.3,7 However, the molecular mechanisms responsible for the
embryonic development of HCAD are still unknown.
Nitric oxide (NO) is produced from the guanidino group of
L-arginine in an NADPH-dependent reaction catalysed by a
family of NO synthase (NOS) enzymes.8 Originally identified as a
vasodilatory agent, NO is now recognized as an important signalling molecule involved in a wide range of physiological processes
including apoptosis, angiogenesis and cell growth.8,9 There are
three distinct isoforms of NOS: neuronal NOS (nNOS, NOS1), inducible NOS (iNOS, NOS2), and endothelial NOS (eNOS,
NOS3). Interestingly, NOS3 is expressed in cardiomyocytes
during early mammalian embryonic heart development.10 Immunohistochemical analysis revealed that the heart starts to express
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NOS3 at E9.5 and the expression remains high until E13.5. Starting
from E14.5 the levels of NOS3 expression decrease in both atria
and ventricles.10 The expression of NOS3 in the heart peaks
during coronary artery development,10,11 suggesting its potential

importance. However, the role of NOS3 in embryonic coronary
artery development is still not clear.
The signalling milieu within the developing heart is critical to
coronary vasculogenesis.11 Transcription factors, such as Gata4
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Figure 1 Generation of mice with cardiomyocyte-specific overexpression of human nitric oxide synthase-3 during embryonic development.
(A) Construct used for the generation of mice with cardiomyocyte-specific overexpression of hu-NOS3 under the control of b-myosin heavy
chain. (B) NOS3 protein levels in the heart at E12.5, P0 and 5 months of age by western blot analysis. Tg; 2/2 and Tg;+/+ indicate
NOS3Tg;NOS32/2 and NOS3Tg, respectively. (C) The expression of the hu-NOS3 transgene was restricted in the heart at P0. Hu-NOS3
mRNA was analysed by RT – PCR. (D) NOS3 immunostaining at E12.5 showing the expression of the Hu-NOS3 transgene. Endogenous
NOS3 expression was mostly located in the endocardium and capillary endothelium in the NOS3+/+ mice. NOS32/2 mice showed no detectable expression of NOS3. NOS3Tg;NOS32/2 mice showed strong NOS3 expression in the myocardium, but not in the endocardium or capillary endothelium. NOS3Tg mice showed strong NOS3 expression in the myocardium (transgene), endocardium, and capillary endothelium
(endogenous). Scale bar ¼ 30 mm.
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and Wilms tumour-1 (Wt1),12,13 as well as growth factors, including the vascular endothelial growth factor (VEGF), basic fibroblast
growth factor (bFGF), and erythropoietin (EPO),14,15 are essential
in the formation of coronary arteries.11,15 We have previously
shown a key role of NOS3 to capillary vessel development in
the heart.16 In the present study, we hypothesized that NO production from NOS3 within the embryonic heart is a critical signalling molecule in the development of coronary arteries and
deficiency in NOS3 results in hypoplastic coronary arteries.

Methods
For complete methods, see Supplementary material online.

Results
Characterization of NOS3Tg and
NOS3Tg;NOS32/2 mice
To study the specific role of NOS3 transgenic mouse (NOS3) in
coronary artery development, a cardiac-specific NOS3Tg was generated under the control of a b-myosin heavy chain promoter.17
Expression of human NOS3 was detected only during embryonic
development and specifically in the heart of NOS3Tg mice
(Figure 1A– D). The NOS3Tg mice were then crossed with
NOS32/2 to create the NOS3Tg;NOS32/2 mouse, an animal
that lacks NOS3 in all organs except the heart during embryogenesis (Figure 1B and D). cGMP, a critical downstream signalling molecule of NOS3, was significantly decreased in the NOS32/2
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Figure 2 Myocardial infarction and postnatal survival in NOS32/2 mice. (A) Evidence of spontaneous myocardial infarction in NOS32/2 mice
at P0. Triphenyltetrazolium chloride (TTC) staining shows a large area of tissue death near the apex of the heart. The images are adjacent cross
sections of the heart near the apex. Troponin I staining shows a significant loss of troponin I in the infarct myocardium. Haematoxylin/eosin
staining shows the waviness of fibres near the border of the myocardium with intense eosinophilic cytoplasm. ECG tracing shows significant
ST-elevation (arrows) and QRS inversion (arrowheads), representing signs of myocardial ischaemia, and possible cardiac hypertrophy, respectively. White bar: 1 mm. Black bar: 40 mm. (B) Spontaneous myocardial infarction in NOS32/2 animals at P0. *P , 0.01 vs. NOS3+/+ ,
NOS3Tg;NOS32/2 and NOS3Tg mice. Tg; 2/2 and Tg;+/+ indicate NOS3Tg;NOS32/2 and NOS3Tg, respectively. (C and D) Heart function
assessed by echocardiography in NOS3+/+ , NOS32/2 , NOS3Tg;NOS32/2 , and NOS3Tg mice at P0; n ¼ 5 – 6 mice per group. *P , 0.01 vs.
NOS3+/+ mice. †P , 0.01 vs. NOS32/2 . (E) Thirty-day survival after birth in NOS3+/+ , NOS32/2 , NOS3Tg;NOS32/2 , and NOS3Tg mice.
*P , 0.001 vs. NOS3+/+ , NOS3Tg;NOS32/2 , and NOS3Tg mice.
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a-actin to identify coronary arteries. Coronary arteries were smaller and less abundant in NOS32/2 and NOS3+/2 compared with the
NOS3+/+ mice. Cardiac-specific overexpression of NOS3 (NOS3Tg;NOS32/2 ) restored coronary abundance in the NOS32/2 mice. Coronary
arteries are indicated by red arrows. Scale bar ¼ 60 mm. (B – D) Left and right coronary artery diameter and abundance measured at 50 mm
from the aortic orifice were significantly decreased NOS32/2 and NOS3+/2 compared with the NOS3+/+ mice, which was restored in
the NOS3Tg;NOS32/2 mice; n ¼ 5 hearts per group.*P , 0.01 vs. NOS3+/+ , †P , 0.01 vs. NOS3+/2 . ‡P , 0.01 vs. NOS32/2 . Tg; 2/2
and Tg;+/+ indicate NOS3Tg;NOS32/2 and NOS3Tg, respectively. (E) The coronary artery volume was significantly decreased NOS32/2
and NOS3+/2 compared with the NOS3+/+ mice, which was restored in NOS3Tg;NOS32/2 mice. n ¼ 5 hearts per group. *P , 0.01 vs.
NOS3+/+ . †P , 0.01 vs. NOS32/2 .

compared with NOS3+/+ hearts at postnatal day 0 (P0) (data not
shown).

Deficiency in NOS3 results in
spontaneous myocardial infarction
Deficiency in NOS3 resulted in 73% mortality within the first 4
days after birth (Figure 2E). To assess if myocardial infarction
was the cause of death, P0 hearts were subjected to triphenyltetrazolium chloride (TTC), troponin I, and haematoxylin/eosin

(H/E) staining. Triphenyltetrazolium chloride staining showed
that the NOS32/2 mice had a large area of tissue death near
the apex of the heart (Figure 2A). Troponin I is a part of the
troponin complex that is integral to muscle contraction and
decreased levels of troponin I represent cardiomyocyte
death.18 Our data showed troponin I immunostaining was
decreased in the area of infarct in the NOS32/2 mice
(Figure 2A). Haematoxylin/eosin staining showed typical wavy
fibres near the border of the infarct area with disappearance
of nuclei and intense eosinophilic cytoplasm (Figure 2A), which
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Figure 3 Immunohistochemical analysis of coronary artery development at P0. (A) Heart sections were stained with vascular smooth muscle
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are signs of acute myocardial infarction.19 ECG monitoring
showed ST-elevation and QRS inversion in neonatal NOS32/2
mice, indicating myocardial ischaemia and possible cardiac
hypertrophy, respectively (Figure 2A). Spontaneous myocardial
infarction was seen in 8/15 (53%) NOS32/2 animals at P0
(Figure 2B). Consequently, left ventricular ejection fraction and

fractional shortening were significantly decreased in the
NOS32/2 compared with NOS3+/+ mice (P , 0.05, Figure 2C
and D). These abnormalities in the NOS32/2 mice including
myocardial infarction, cardiac dysfunction, and postnatal mortality were all rescued by cardiac-specific overexpression of NOS3
(NOS3Tg;NOS32/2 mice, Figure 2A – E).
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Figure 4 Three-dimensional reconstruction of coronary artery development at P0. (A) Coronary arteries shown in green were less abundant
in NOS32/2 and NOS3+/2 compared with the NOS3+/+ mice. Cardiac-specific overexpression of NOS3 restored coronary artery abundance
in the NOS32/2 mice. Atria were excluded from the reconstruction in order to view the origins of the coronary arteries. (B and C ) Ventricular
wall thickness and myocardial volume were significantly increased in NOS32/2 and NOS3+/2 compared with NOS3+/+ mice. Cardiac overexpression of NOS3 (NOS3Tg;NOS32/2 ) restored myocardial thickness and volume to similar levels as in the NOS3+/+ mice. (D and E) Cross
section of cardiomyocyte cell size and nucleus size was significantly increased NOS32/2 and NOS3+/2 compared with NOS3+/+ mice. Cardiac
overexpression of NOS3 (NOS3Tg;NOS32/2 ) restored myocardial thickness to similar levels as in the NOS3+/+ mice; n ¼ 4 hearts per group.
*P , 0.01 vs. NOS3+/+ mice, †P , 0.01 vs. NOS3+/2 mice, ‡P , 0.01 vs. NOS32/2 . Tg; 2/2 and Tg;+/+ indicate NOS3Tg;NOS32/2 and
NOS3Tg, respectively.
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Deficiency in NOS3 impairs coronary
artery development
NOS32/2 and NOS3+/2 hearts at P0 showed less branching and significant decrease in the left and right coronary artery diameters
(Figure 3A–D). Three-dimensional reconstructions of the heart

showed a significant decrease in the coronary volume in the
NOS32/2 mice (P , 0.01, Figures 3E and 4A and Supplementary material online, Videos S1–3). Cardiomyocyte-specific NOS3 overexpression
completely rescued these defects in the NOS32/2 mice (Figures 3A–E
and 4A and Supplementary material online, Videos S4 and 5).
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Figure 5 Coronary artery development at E15.5. (A) Three-dimensional reconstruction of E15.5 hearts. Coronary arteries shown in green
were less abundant in NOS32/2 compared with NOS3+/2 and NOS3+/+ mice. Cardiac-specific overexpression of the NOS3 restored coronary artery abundance in the NOS32/2 mice. Atria were excluded from the reconstruction in order to view the origins of the coronary arteries. (B –E) Coronary artery vessel diameter, abundance, and volume were significantly decreased in the NOS32/2 mice compared with
NOS3+/2 and NOS3+/+ , which were restored in NOS3Tg;NOS32/2 mice; n ¼ 5 hearts per group. Tg; 2/2 and Tg;+/+ indicate
NOS3Tg;NOS32/2 and NOS3Tg, respectively. (F) Ventricular wall thickness was significantly increased in NOS32/2 compared with
NOS3+/2 and NOS3+/+ mice. Cardiomyocyte-specific overexpression of NOS3 (NOS3Tg;NOS32/2 ) restored myocardial thickness to
similar levels as in the NOS3+/+ mice; n ¼ 4 hearts per group. For (B)– (F), *P , 0.01 vs. NOS3+/+ mice, †P , 0.01 vs. NOS32/2 .
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VEGFa, bFGF, and EPO were analysed by real-time RT – PCR. The mRNA levels of Gata4, VEGFa, bFGF, and EPO were significantly decreased in
NOS32/2 compared with NOS3+/+ mice, which were restored by cardiac-specific NOS3 overexpression in the NOS3Tg;NOS32/2 hearts;
n ¼ 6 – 7 per group. *P , 0.01 vs. NOS3+/+ mice. †P , 0.01 vs. NOS32/2 mice. Tg; 2/2 and Tg;+/+ indicate NOS3Tg;NOS32/2 and
NOS3Tg, respectively. (E – H) E12.5 ex vivo heart cultures were used to investigate NOS3 signalling. Cultured NOS3+/+ and NOS32/2
hearts were treated with 100 mM ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) a soluble guanylate cyclase inhibitor, or 2 mM
8-Br-cGMP, a cGMP analogue, for 6 h. ODQ decreased Gata4 and Wt1 mRNA levels in NOS3+/+ hearts, whereas 8-Br-cGMP restored
Gata4 and Wt1 mRNA levels in NOS32/2 hearts; n ¼ 3 – 4 heart cultures per group. *P , 0.05 vs. controls.

Since a decrease in the coronary artery volume may have been a
result of a smaller myocardial mass, myocardial volume, and thickness were analysed. However, both myocardial volume and thickness were increased in NOS32/2 and NOS3+/2 compared with
the NOS3+/+ mice (P , 0.01, Figure 4B and C). To determine
whether the increased myocardial volume and thickness are a
result of cardiac hypertrophy, cardiomyocyte cell size and nuclear
size of P0 hearts were measured. The cardiomyocyte cell size and

nuclear size were progressively increased in NOS32/2 and
NOS3+/2 compared with the NOS3+/+ mice (P , 0.01, Figure 4D
and E). Therefore, our data showed an increased myocardial mass
accompanied by severe coronary artery hypoplasia. These defects
in the NOS32/2 mice were completely rescued by cardiomyocytespecific NOS3 overexpression (P , 0.01, Figure 4B–E).
The coronary artery network is established by E15.5 in mice.11
To assess the onset of the coronary artery malformations, we
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Figure 6 Myocardial mRNA expression of transcription and growth factors. (A – D) E12.5 hearts were collected and mRNA levels of Gata4,
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Figure 7 The characterization and quantification of Wt1+ epicardial progenitor cells. (A) E12.5 hearts were immunostained for Wt1 and

representative images from NOS3+/+ , NOS32/2 , NOS3Tg;NOS32/2 , and NOS3Tg hearts are shown. The majority of Wt1+ cells are in
the epicardium with limited expression in the myocardium. Scale bar ¼ 60 mm. (B) Quantitative analysis showed a significant reduction in
Wt1+ epicardial cells in NOS32/2 compared with NOS3+/+ hearts, which was restored by cardiac-specific NOS3 overexpression in the
NOS3Tg;NOS32/2 hearts; n ¼ 4 – 5. (C) Wt1 mRNA levels were analysed in E12.5 hearts by real-time RT – PCR. Wt1 mRNA expression
was significantly decreased in the NOS32/2 compared with NOS3+/+ hearts, which was restored in NOS3Tg;NOS32/2 hearts; n ¼ 6 – 7
per group. For (B) and (C), *P , 0.01 vs. NOS3+/+ mice, †P , 0.01 vs. NOS32/2 . Tg; 2/2 and Tg;+/+ indicate NOS3Tg;NOS32/2 and
NOS3Tg, respectively.

928
further analysed coronary artery development at E15.5. Coronary
artery abundance, vessel diameter, and volume were all significantly decreased, whereas the myocardial thickness was increased in
NOS32/2 compared with the NOS3+/2 and NOS3+/+ mice at
E15.5 (P , 0.01, Figure 5A –F). These results suggest that the
onset of the defect is prior to E15.5. Consistent with our P0

Y. Liu et al.

data, these defects were completely rescued by cardiomyocytespecific NOS3 overexpression (P , 0.01, Figure 5A– F). Since coronary artery formation at E15.5 was not impaired in the
NOS3+/2 mice, all subsequent molecular analyses on early coronary artery development were carried out in NOS32/2 in comparison with the NOS3+/+ mice.
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Down-regulation of transcription and
growth factors in E12.5 NOS32/2 hearts

Deficiency in NOS3 decreases
epicardium-derived cells migration
Epicardium-derived cells (EPDCs) express Wt1 and their migration
into the myocardium is essential to the formation of coronary arteries.13,20 The number of Wt1+ epicardial cells was significantly
decreased in NOS32/2 compared with NOS3+/+ hearts at
E12.5 (P , 0.01, Figure 7A and B). In addition, myocardial Wt1
mRNA levels were also significantly decreased in NOS32/2 compared with the NOS3+/+ mice (P , 0.01, Figure 7C). The
decreased myocardial expression of Wt1 and number of Wt1+
epicardial cells were rescued in the NOS3Tg;NOS32/2 mice
(P , 0.01, Figure 7A–C). To study the role of NOS3 in EPDCs migration, a co-culture system was employed (Figure 8A). Epicardiumderived cells were isolated from E13 embryos overexpressing
enhanced green fluorescence protein (eGFP). The cultured
EPDCs were typical cobble stone shape and 100% positive for epicardin and Wt1. Cardiomyocytes was verified by a-actinin staining
(Figure 8B). eGFP+ EPDCs were then co-cultured with either E13
NOS3+/+ or NOS32/2 cardiomyocytes treated with adenoviral
lacZ or adenoviral NOS3 for 72 h. Our data showed that the migration of eGFP+ EPDCs was significantly decreased towards the
NOS32/2 compared with the NOS3+/+ cardiomyocytes

Discussion
Growing evidence suggests that NO plays an important role in embryonic heart development. To this end, we and others have previously shown that lack of NOS3 results in congenital septal
defects and bicuspid aortic valves in mice.21 – 24 In addition,
impaired capillary and microvessel development has been shown
in the heart and lungs of the NOS32/2 mice, respectively.16,25
The present study was carried out to further examine the role
of NOS3 in coronary artery development. We demonstrated for
the first time that the deficiency of NOS3 leads to hypoplastic coronary arteries. These results show that NOS3 plays a critical role
in normal coronary artery development (Figure 8G). To rescue the
coronary phenotype in the NOS32/2 mice, we generated a mouse
with cardiomyocyte-specific overexpression of NOS3 during embryonic development. The NOS3Tg mice had a normal cardiac
and coronary artery phenotype. Importantly, cardiomyocytespecific overexpression of NOS3 completely rescued the abnormal coronary artery development, cardiac hypertrophy, and postnatal survival in the NOS32/2 mice. The data strongly suggest that
normal coronary artery development is driven by local NO signalling from endothelial cells and/or cardiomyocytes within the developing heart.
A classic pathway by which NO mediates its biological function
is through cGMP-dependent protein kinase G (PKG) signalling.26
Activation of PKG has been shown to up-regulate Gata4 and
Wt1.27,28 Thus, a deficiency in NOS3 decreases NO and cGMP
production, and may lead to decreased PKG activation and downregulation of Gata4 and Wt1 expression. Gata4 is a master regulator of heart development, and controls the expression of many
growth factors including VEGFa, bFGF, and EPO, that are

Figure 8 Migration of epicardium-derived cells. (A) Epicardium-derived cells were isolated from E13 hearts and co-cultured with cardiomyocytes as shown. The number of epicardium-derived cells migrated towards the cardiomyocytes was determined. (B) A representative confocal
tiled image of the epicardium-derived cells and cardiomyocyte co-culture. Epicardium-derived cells (green) and cardiomyocytes were isolated
from enhanced green fluorescence protein transgenic and C57BL6 wild-type mice, respectively. Cardiomyocytes were stained with cardiac
a-actinin (red). (C) Quantitative analysis from (D) shows that epicardium-derived cell migration was significantly decreased in NOS32/2 compared with NOS3+/+ cardiomyocyte co-cultures, which was restored by adenoviral NOS3 treatment; n ¼ 3 – 5 per group. *P , 0.01 vs.
NOS3+/+ mice. †P , 0.01 vs. respective Ad-lacZ-treated groups. (D) NOS3 expression in cardiomyocytes promoted epicardium-derived
cell migration. Representative confocal tiled images of eGFP+ epicardium-derived cells co-cultured with NOS3+/+ and NOS32/2 cardiomyocytes, which were treated lacZ or NOS3 adenoviral constructs. (E) Representative images of the epicardium-derived cell outgrowth of E12.5
NOS3+/+ and NOS32/2 hearts. Scale bar ¼ 250 mm. (F) Quantitative analysis shows that maximum epicardium-derived cell migration distance
was significantly decreased in NOS32/2 hearts compared with NOS3+/+ hearts; n ¼ 7 – 8, *P , 0.01 vs. NOS3+/+ heart. (G) The proposed
signalling pathway of NOS3 on coronary artery development. NOS3 promotes the expression of Gata4 and Wt1 via cGMP-dependent mechanisms. The production of growth factors (vascular endothelial growth factor-a, basic fibroblast growth factor, and erythropoietin) by Gata4 and
epicardium-derived cells migration by Wt1 contribute to the critical role of NOS3 on coronary artery development.
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Capillary networks in the embryonic heart begin to develop at
E12.5, and are regulated by transcription and growth factors that
are critical to heart morphogenesis and coronary artery formation.11 Our data showed that the mRNA levels of Gata4, VEGFa,
bFGF, and EPO were significantly decreased in the NOS32/2 compared with NOS3+/+ hearts, and were completely restored in the
NOS3Tg;NOS32/2 hearts (P , 0.05, Figure 6A–D). Treatment with
ODQ, (1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one) a soluble
guanylyl cyclase inhibitor significantly decreased Gata4 and Wt1
mRNA expression in the NOS3+/+ hearts (P , 0.05, Figure 6E
and F ). Conversely, NOS32/2 hearts treated with 8-bromo-cGMP,
a cGMP analogue showed a significant increase in Gata4 and Wt1
mRNA levels (P , 0.05, Figure 6G and H ). These data suggest that
NOS3 regulates the expression of Gata4 and Wt1 through a
cGMP-dependent signalling pathway.

(Figure 8C and D). However, EPDC migration was increased in cardiomyocytes treated with adenoviral NOS3 compared with adenoviral lacZ controls (Figure 8C and D). Finally, to assess the migration
and proliferation of EPDCs in the developing heart, ex vivo heart
explants were employed. Our data showed that ex vivo EPDC migration and proliferation were significantly decreased in the
NOS32/2 compared with NOS3+/+ hearts (P , 0.01, Figure 8E
and F ).
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important for coronary vessel formation.12,29,30 Our data showed
that deficiency in NOS3 down-regulated the expression of
Gata4, VEGFa, bFGF, and EPO in the embryonic heart. Additionally, Wt1, a transcription factor critical for epithelial and mesenchymal transition and coronary artery formation, was also
down-regulated and the number of EPDCs was decreased in the
NOS32/2 hearts. Furthermore, lack of NOS3 decreased EPDCs
migration towards the cardiomyocytes. Our results suggest that
NOS3 promotes normal coronary artery development via
increases in the expression of transcription and growth factors,
and EPDCs migration into the myocardium (see Figure 8G).
NOS32/2 mice have a high rate of postnatal mortality. We have
previously shown that within 10 days after birth, mortality was 85,
38, and 13% for NOS32/2 , NOS3+/2 , and NOS3+/+ mice, respectively.21 Most animals died within the first 3 days after birth.
Consistent with our finding, Han et al.25 showed that 40% of
NOS32/2 offspring succumbed within the first hour of birth.
However, they did not monitor their animal survival beyond 1
hour of birth. In the present study, the mortality of the
NOS32/2 mice was 73% in the first 4 days after birth, which is
in agreement with the previous studies.21,25 Additionally, we
demonstrated a dose-dependent cardiac dysfunction at P1 with
the loss of one or both NOS3 alleles.21 Interestingly, this gene
dose-dependent response was also observed in the coronary
artery formation of NOS32/2 , NOS3+/2 , and NOS3+/+ mice at
P0 in the present study. These data suggest that hypoplastic coronary arteries may contribute at least in part to postnatal cardiac dysfunction and mortality in the NOS32/2 mice.
Hypoplastic coronary artery disease is often associated with
myocardial infarction and sudden cardiac death when the heart is
stressed.7 In the present study, coronary artery malformation is accompanied by spontaneous myocardial infarction in postnatal
NOS32/2 mice. Our study demonstrated that NOS3 deficiency
results in hypoplastic coronary arteries, a condition that mirrors
HCAD in humans. Interestingly, recent studies have shown that a
common 894G.T single nucleotide polymorphism, which
reduces NOS3 activity, is associated with an increased risk of congenital heart disease, especially conotruncal heart defects.31 In addition, environmental factors and maternal conditions including
psychological stress, hypertension, and diabetes, which decrease
NOS3 expression and/or activity, are associated with increased
risks of congenital heart disease.32 – 34 Thus, it is possible that
decreased NOS3 signalling may promote the development of congenital heart disease in patients with these environmental and maternal conditions. Although further studies are required to analyse
NOS3 gene mutation in patients with HCAD, the present study
suggests that NOS3 is critical to coronary artery development
and deficiency or mutation of NOS3 gene may lead to HCAD.
Our study is the first to implicate NOS3 deficiency in the pathogenesis of HCAD and may help to design strategies in the diagnosis, prevention, and treatment of HCAD in humans.

Y. Liu et al.

931

NOS3 and hypoplastic coronary arteries

30. Heineke J, Auger-Messier M, Xu J, Oka T, Sargent MA, York A, Klevitsky R,
Vaikunth S, Duncan SA, Aronow BJ, Robbins J, Crombleholme TM,
Molkentin JD. Cardiomyocyte GATA4 functions as a stress-responsive regulator
of angiogenesis in the murine heart. J Clin Invest 2007;117:3198 –3210.
31. van Beynum IM, Mooij C, Kapusta L, Heil S, den Heijer M, Blom HJ. Common
894G.T single nucleotide polymorphism in the gene coding for endothelial
nitric oxide synthase (eNOS) and risk of congenital heart defects. Clin Chem
Lab Med 2008;46:1369 – 1375.
32. Lisowski LA, Verheijen PM, Copel JA, Kleinman CS, Wassink S, Visser GH,
Meijboom EJ. Congenital heart disease in pregnancies complicated by maternal
diabetes mellitus. An international clinical collaboration, literature review, and
meta-analysis. Herz 2010;35:19 –26.
33. Andersen MR, Simonsen U, Uldbjerg N, Aalkjaer C, Stender S. Smoking
cessation early in pregnancy and birth weight, length, head circumference,
and endothelial nitric oxide synthase activity in umbilical and chorionic
vessels: an observational study of healthy singleton pregnancies. Circulation
2009;119:857 – 864.
34. Michel T, Vanhoutte PM. Cellular signaling and NO production. Pflugers Arch 2010;
459:807–816.

CARDIOVASCULAR FLASHLIGHT

doi:10.1093/eurheartj/eht355
Online publish-ahead-of-print 29 August 2013

.............................................................................................................................................................................

Renal artery fibromuscular dysplasia: in vivo optical coherence tomography
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A 66-year-old woman with long-term essential hypertension presented with poorly controlled blood pressure in spite of six antihypertensive drugs. Percutaneous renal denervation was indicated as a
treatment of resistant arterial hypertension. Renal angiography
showed ‘strings of beads’ appearance characteristic of fibromuscular
dysplasia (FMD) in the mid-segment of the right renal artery (Panel A).
Optical coherence tomography (OCT) confirmed the diagnosis
of medial fibroplasia showing the ‘strings and beads’ appearance in
the longitudinal reconstruction (Panel B). Cross-sectional images
showed several luminal stenosis due to media layer hyperplasia
and fibrosis, with areas of intimo-media layer dissections and aneurysm formations, alternating with segments of normal three-layer appearance (Panels C–I). (Panel C) Three-layer appearance of the
arterial wall (intima: white arrow, media: blue arrow, adventitia:
yellow arrow) at the bottom and medial fibroplasia (asterisks)
with an intimal dissection (red arrow) communicating with a little
aneurysm formation at the top. Medial fibroplasia contains areas
of low backscattering probably related with muscle cells and areas
of high backscattering in the inner half of the media corresponding
with collagen deposition. (Panel D) three-layer appearance. (Panel E)
intimo-medial dissection (red arrow). (Panel F) Luminal stenosis secondary to focal medial fibroplasia (asterisk). (Panel G) Ruptured medial fibroplasia with an aneurysm formation. (Panel H) Another intimomedial dissection (red arrow). (Panel I) Small medial fibroplasia that protrudes into the lumen of the renal artery. As this case illustrates,
OCT provides unique insights on the underlying pathology of FMD, showing detailed ‘in vivo’ histology information.
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